1. Ling, Y., J. Li and L. Zhou, 2023. Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer. Int. J. Immunopathol. Pharmacol., Vol. 37. 10.1177/03946320231166774.
   CrossRef  |  Direct Link  |  
2. Hu, C., T. Guo, Y. Zou, J. Gao and Y. Gao et al., 2023. Discovery of dual S-RBD/NRP1-targeting peptides: Structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies. J. Enzyme Inhib. Med. Chem., Vol. 38. 10.1080/14756366.2023.2212327.
   CrossRef  |  Direct Link  |  
3. Yin, S., S. Mei, Z. Li, Z. Xu and Y. Wu et al., 2022. Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.1037993.
   CrossRef  |  Direct Link  |  
4. Xu, Z., Y. Zou, X. Gao, M.M. Niu, J. Li, L. Xue and S. Jiang, 2022. Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.1041331.
   CrossRef  |  Direct Link  |  
5. Wang, Y., H. Zhang, J. Li, M.M. Niu, Y. Zhou and Y. Qu, 2022. Discovery of potent and noncovalent KRAS^G12D inhibitors: Structure-based virtual screening and biological evaluation. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.1094887.
   CrossRef  |  Direct Link  |  
6. Chen, L., N. Wei, Y. Jiang, C. Yuan and L. Xu et al., 2022. Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS. J. Ethnopharmacol., Vol. 303. 10.1016/j.jep.2022.116035.
   CrossRef  |  Direct Link  |  
7. Chen, L., H. Chen, Q. Yang, Y. Jiang and L. Liu et al., 2022. Guizhi fuling capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway. J. Ethnopharmacol., Vol. 290. 10.1016/j.jep.2022.115115.
   CrossRef  |  Direct Link  |  
8. Zhen, X., L. Jindong, Z. Yang, R. Yashi and G. Wei et al., 2021. Activation of Nrf2 pathway by dimethyl fumarate attenuates renal ischemia-reperfusion injury. Transplant. Proc., 53: 2133-2139.
   CrossRef  |  Direct Link  |  
9. Chen, K., J. Qu, H. Chen, J. Wang and H. Hua et al., 2021. Investigating the medicinal potential, material basis and mechanism of Polygoni Orientalis fructus based on multi-technology integrated network pharmacology. Phytomedicine, Vol. 91. 10.1016/j.phymed.2021.153685.
   CrossRef  |  Direct Link  |  
10. Yao, H., X. Zhang, N. Zhang, J. Li, Y. Li and Q. Wei, 2020. Wikstromol from Wikstroemia indica induces apoptosis and suppresses migration of MDA-MB-231 cells via inhibiting PI3K/Akt pathway. J. Nat. Med., 75: 178-185.
    CrossRef  |  Direct Link  |  
11. Yao, H., N. Zhang, W. Zhang, J. Li, H. Hua and Y. Li, 2020. Discovery of polypodiside as a Keap1-dependent Nrf2 activator attenuating oxidative stress and accumulation of extracellular matrix in glomerular mesangial cells under high glucose. Bioorg. Medic. Chem., 10.1016/j.bmc.2020.115833.
    CrossRef  |  Direct Link  |  
12. Yao, H., N. Zhang, W. Zhang, J. Li, H. Hua and Y. Li, 2020. Discovery of a coumarin derivative as Nrf2 activator mitigating oxidative stress and fibrosis in mesangial cells under high glucose. Bioorg. Medic. Chem. Lett., 10.1016/j.bmcl.2020.127490.
    CrossRef  |  Direct Link  |